Development of the mammalian lung is predicated on cross-communications between two highly interactive tissues, the endodermally derived epithelium and the mesodermally derived pulmonary mesenchyme. While much attention has been paid for the lung epithelium, the pulmonary mesenchyme, partly due to lack of specific tractable markers remains underinvestigated. The lung mesenchyme is derived from the lateral plate mesoderm and is the principal recipient of Hedgehog (Hh) signaling, a morphogenetic network that regulates multiple aspects of embryonic development. Using the Hh-responsive Gli1-cre ERT2 mouse line, we identified the mesodermal targets of Hh signaling at various time points during embryonic and postnatal lung development. Cell lineage analysis showed these cells serve as progenitors to contribute to multiple lineages of mesodermally derived differentiated cell types that include parenchymal or interstitial myofibroblasts, peribronchial and perivascular smooth muscle as well as rare populations of cells within the mesothelium. Most importantly, Gli1-cre ERT2 identified the progenitors of secondary crest myofibroblasts, a hitherto intractable cell type that plays a key role in alveolar formation, a vital process about which little is currently known. Transcriptome analysis of Hh-targeted progenitor cells transitioning from the pseudoglandular to the saccular phase of lung development revealed important modulations of key signaling pathways. Among these, there was significant downregulation of canonical WNT signaling. Ectopic stabilization of b-catenin via inactivation of Apc by Gli1-cre ERT2 expanded the Hh-targeted progenitor pools, which caused the formation of fibroblastic masses within the lung parenchyma. The Gli1-cre ERT2 mouse line represents a novel tool in the analysis of mesenchymal cell biology and alveolar formation during lung development. STEM CELLS 2015;33:999-1012 
INTRODUCTION
Development of vertebrate organs is initiated by specification of a primordium within the early embryo and usually requires contributions from more than one germ layer. Ontogeny and development of the mammalian lung is no exception and requires contributions from at least two highly interactive embryonic tissues, the endodermally derived epithelium and the mesodermally derived pulmonary mesenchyme. Epithelial-mesenchymal interactions are centerpiece in both structural development of the lung as well as differentiation of its many highly specialized cell types.
While the last two decades have witnessed extensive analysis of the lung epithelium, the pulmonary mesoderm, partly due to lack of specific markers has been less tractable. The pulmonary mesenchyme is derived from the lateral plate mesoderm, which forms in the early embryo subsequent to gastrulation. One of the earliest mesodermal cell types to differentiate in the embryonic lung is distinguished by ACTA2 (alpha smooth muscle actin) expression. In the adult lung, the ACTA2-expressing lineages can be viewed as belonging to two large classes of mesodermally derived cell populations; smooth muscle cells and myofibroblasts. As early as embryonic day E11.5, ACTA2-expressing smooth muscle cells are found as distinct cell layers around the nascent airways and the mainstem bronchi that are formed by the first endodermal bifurcation. As development of the airways proceeds in a proximo-distal direction, the ACTA2-expressing smooth muscle lineage contributes to peribronchial and perivascular smooth muscle fibers (PBSM and PVSM, respectively) and possibly cells known as pericytes. Abnormalities in these structures have profound consequence on normal airway and vascular function and lead to diseases such as asthma and pulmonary hypertension. The lung mesoderm also serves as the source of interstitial myofibroblasts (IMF), the contractile fibroblasts that express ACTA2. During early lung development (before saccular stage), progenitors of IMFs are scattered in the parenchyma of the lung. In these cells, ACTA2 is undetectable or absent, and no marker has been reported to distinguish them from other fibroblast progenitors. However, platelet-derived growth factor receptor alpha (PDGFRa) was reported as a marker for IMF progenitors in saccular lungs [1, 2] . In the adult lung, IMFs appear as ACTA2 pos cells embedded in the alveolar parenchyma but in much reduced numbers [3] . The function of IMF in the adult lung remains entirely unknown but the IMFs in the perinatal lung are the source of alveolar or secondary crest myofibroblasts (SCMFs). SCMFs are located at the tip of secondary crest structures during the saccular and alveolar phases of lung development. SCMFs have remained a highly intractable, elusive cell type, and there is urgent need to gain a better understanding of their biology. SCMFs play a key role in alveolar formation. In human preterm neonates, interruption in alveogenesis underlies the pathogenesis of the chronic lung disease known as bronchopulmonary dysplasia (BPD). In adults, destruction of alveoli is a hallmark of emphysema and chronic obstructive pulmonary disease (COPD). Both the neonatal and adult manifestations of alveolar defects are highly morbid and can be lethal.
During embryonic development, the lung mesenchyme is the principal recipient of Hedgehog (Hh) signaling, an evolutionarily highly conserved morphogenetic network that regulates multiple aspects of development in vertebrate and invertebrate alike. Sonic hedgehog (Shh) is expressed by the lung epithelium, and it is thought to activate signaling in what has been named the "sub-epithelial mesenchyme" [4] to initiate a cascade of gene expression. Shh(2/2) lungs are profoundly abnormal, failing to undergo normal branching morphogenesis [5] . Importantly, Shh(2/2) lungs are reported to be entirely devoid of ACTA2-expressing cells. This places Hh signaling at the top of a putative regulatory cascade that controls the commitment and differentiation of multipotential mesenchymal cell progenitors along the ACTA2 pos cell lineages. Hh signaling is initiated upon binding of secreted Hh ligands to a receptor, Patched1 (Ptch1). In the absence of Hh ligands, Ptch1 inhibits the signaling activity of Smoothened (Smo), a seven transmembrane protein that shares sequence homology with G-protein coupled receptors. Binding the ligand releases Ptch1-mediated repression of Smo, activating its function at the cell surface that leads to transcriptional induction of the Hh signaling cascade. In Drosophila, Hh signaling is mediated solely by the zinc finger containing transcription factor family cubitus interruptus, ci/Gli [6, 7] . In vertebrates, three Gli molecules, Gli1, Gli2, and Gli3 function downstream of Hh signaling. That Gli1 is a direct transcriptional target of Hh signaling is supported by the results of many studies. For example, ectopic Shh induces Gli1 expression [8] [9] [10] [11] and in the absence of Shh, Gli1 is not expressed [12] . Thus, Hh activity is both necessary and sufficient for Gli1 transcription. Recently Ahn and Joyner [13] generated mice carrying a knockin allele of Gli1-cre
ERT2
. Gli1-Cre ERT2 is expressed exclusively in cells that have received positive Hh signaling and only in the presence of tamoxifen (Tam). In these mice, addition of Tam defines the time point at which Gli1-expressing cells are marked. Thereafter, the progeny of such cells can be followed with GFP using ROSA mTmG reporter mice. Thus, Gli1-Cre ERT2 represents an inducible, highly reliable tool in genetic fate-mapping strategy to identify Hhresponding cells and their descendents during the process of development and postnatally only in the presence of Tam.
In this work, we have used the ability of Gli1-Cre ERT2 to permanently label progenitor cell populations that are recipients of Hh signaling during early embryonic and postnatal development of the murine lung. By cell lineage analysis, we show that the targets of Hh signaling in the early lung serve as progenitors to contribute to a number of mesodermally derived differentiated cell types. The Gli1-Cre
-tagged cells contribute to the IMF cell population and are found in the PBSM and PVSM layers as well as within the mesothelium.
Most importantly, we demonstrate that Hh-tageted mesodermal cells in early embryonic lung (E10.5-E11.5) serve as progenitors to SCMFs. Gene array analysis of Gli1-cre
-tagged cells in early embryonic lungs revealed the involvement of multiple key signaling pathways as such progenitors underwent differentiation during two critical periods of lung development. Ectopic activation of one such pathway, wingless-type MMTV integration site family (WNT) signaling, by targeted genetic inactivation of Apc resulted in expansion of the SCMF progenitor cell population and subsequently lead to formation of multiple myofibroblast masses in the perinatal lungs. The present findings pave the way toward isolation and characterization of SCMF progenitors, an admittedly important cell type whose understanding may be key to elucidating the mechanisms of alveolar formation in normal lung development and failure in both neonatal and adult lung diseases such as BPD and COPD, respectively.
MATERIALS AND METHODS

Mouse Breeding and Genotyping
All animals were maintained and housed in pathogen-free conditions according to the protocol approved by The University of Southern California Institutional Animal Care and Use Committee (IACUC) (Los Angeles, CA). Gli1-cre
ERT2
; ROSA mTmG mice were generated by breeding the Gli1-cre ERT2 [13] 
Immunofluorescent Staining
Immunofluorescent staining was performed as previously described [14] . For oil red O staining, frozen sections of neonatal lungs (8 um) were air dried, washed with tap water, rinsed with 60% isopropanol, and then stained with freshly prepared oil red O solution for 15 minutes. The stained sections were rinsed with 60% isopropanol followed by distilled water and then preserved in VECTASHELD mounting medium with DAPI (to visualize nuclei).
Tamoxifen Administration
Tam was administered by oral gavages. For cell fate of neonatal lungs, two doses of Tam were administered to neonates at postnatal day 5 and 6 (PN5 and PN6). For cell fate of embryonic lungs, timed-pregnant Gli1-cre
ERT2
; ROSA mTmG females received two doses of Tam at embryonic day 10.5 and 11.5 (E10.5 and E11.5). Animals were sacrificed at E12.5 to determine the pattern of Gli1-cre ERT2 labeled cells. For lineagetracing from embryonic stage to postnatal stage, Tam-treated pregnant females were sacrificed, and the pups were extracted by cesarean section at around E18.5. The pups were cleaned, dried, and fed by a foster mother that had delivered her own pups within a 2 day period.
Cell Isolation
Gli1-cre
ERT2
; ROSA mTmG embryonic lungs at stage of E14.5 or E18.5 were dissected in HBSS (GIBCO24020-117). Lung lobes were cut into small pieces, treated in 0.25% Trypsin-EDTA (GIBCO25200-056) at 37 C for 10 minutes, and transferred to 3 ml of Dulbecco's modified Eagle's medium (DMEM)/F12 with 1 mg/ml DNase I (Roche10104159001), followed by repeated pipetting. After adding 20 ml of DMEM/F12 containing 10% fetal bovine serum (FBS), the mixture was pipetted up and down until tissue was completely dissociated. Dissociated cells were filtered through 100 lm and 40 lm cell strainers, centrifuged at 4 C at 1,250 rpm for 5 minutes and resuspended in DMEM/F12. GFP pos cells were isolated by cell sorting (BD FACSAria III). GFP neg cells from ROSA mTmG (cre negative ) lungs isolated under the same condition were used as blank control for cell sorting. Relative abundance of GFP pos cells between E14.5 and E18.5 was calculated by comparison of the number of GFP pos cells from each whole lung, collected by cell sorting. Data represent average of four ratios from four E14.5 and four E18.5 isolations. p value was calculated by one-sample t test (hypothetical mean is 1).
Gene Expression Profiling
Gli1-cre
ERT2
; ROSA mTmG mouse embryonic lungs, which received Tam at E10.5 and E11.5, were dissected at E14.5 and E18.5. GFP pos cells were sorted (BD FACSAria III) and isolated for RNA extraction. RNA was subjected to Whole Mouse Genome Oligo Microarrays (Agilent, Palo Alto, CA, http:// www.agilent.com). Raw intensities were log2-transformed and quantile normalized (Partek Genomics Suite 6.6). We selected probe sets with absolute fold change greater than 2 and a false discovery rate (FDR) value less than 0.05. Genes with raw intensity less than 50 in both stages are not included.
Ingenuity Pathways Analysis software (Ingenuity Systems, Redwood city, CA, http://www.ingenuity.com/) was used to analyze functional relationships of differentially expressed genes.
Realtime PCR
Expression of selected genes was quantified by Realtime PCR using a LightCycler with LightCycler Fast Start DNA Master SYBR Green I Kit (Roche Applied Sciences, IN, http://www. roche-applied-science.com) as previously described [15] . Relative ratio of a target gene transcript in GFP pos cells between E18.5 and E14.5 was calculated with the DDCt method [14] . All primers for Realtime PCR were designed by using the program of Universal ProbeLibrary Assay Design Center from Roche Applied Sciences. Sequences of the primers are listed in Supporting Information Table ST1 .
RESULTS
Labeling of Hh Targets in Embryonic Lungs
To determine an optimal dose of Tam that would activate Gli1-cre ERT2 in the embryonic lung cells receiving Hh signaling, without causing abortion of the fetus, we tested two strategies. (Fig. 1B, 1C , respectively). In both the 18-20 and 24 hour windows, GFP pos cells were localized around the branching epithelium within a region that has been referred to as the sub-epithelial mesenchyme [4] . Scant GFP pos cells were localized close to or within the mesothelium of the lung (arrows). As an alternative to maximize the labeling potential of the Gli1-cre ERT2 we also administered two doses of Tam, 24 hours apart, delivered between E10.5 and E11.5. This regimen significantly increased the number of GFP pos cells in E12.5 lungs (Fig. 1D-1F ). Examination of multiple embryonic lung samples showed that GFP pos cells tagged on E10.5-E11.5 made up nearly 27% (60.075) of the total (DAPI positive) mesenchymal cell population in E12.5 lungs. The majority of these cells were undifferentiated interstitial cells in which ACTA2 was undetectable ( Fig. 1D-1F ). There were also few GFP pos cells near or within the peribronchial smooth muscle or perivascular smooth muscle layers (only PBSM shown). Importantly, these were ACTA2 pos ( Fig. 1D-1F ).
Postnatal Fate of Early Embryonic Hh Targets
Tam remains active for approximately 30 hours [13, 16] . Therefore, we adopted the "two-dose" Tam strategy (described above) and used the observations on E12. Fig. 1G-1I , 1M-1O). As expected, the GFP pos cells within the mesothelium showed no detectable expression of ACTA2 (arrow in Fig. 1G-1I ). GFP pos cells were also found in the two structures composed of smooth muscle cells in PN14 lungs. Both PVSM and PBSM layers in PN14 lungs contained GFP pos cells ( Fig. 1J-1L ).
Progenitors of SCMF are Committed in Early Lung Mesenchyme
We also examined the contribution of (Gli1 pos ) GFP pos cells to the SCMFs. These are ACTA2
pos cells appearing at the tip of the secondary crest found during the process of alveolization and thought to have a major role in this process. Unexpectedly, coimmunostaining with anti-GFP and anti-ACTA2 antibodies revealed that GFP pos cells labeled in E10.5-11.5 lungs or their daughters also contributed to SCMFs, which appear only during alveolar formation. In PN14 Gli1-cre
ERT2
;ROSA mTmG lungs, there were large number of GFP pos areas, within which upward of nearly 95% of the SCMFs were double positive for both GFP and ACTA2 ( Fig. 1M-1O ). Occasionally, ACTA2 pos cells were observed that were not at first sight GFP pos . However, careful examination showed that they were weakly stained with GFP antibody. Finally, due to spatial proximity to SCMFs we also examined whether any of the GFP pos cells identified in PN14 lungs were lipofibroblasts. Using oil red O, it is clear that GFP pos and oil-red-O pos cells are indeed distinct (Fig. 1P ). This evidence shows that the SCMF cell fate is already established in E10.5-E11.5 embryonic lungs, a surprisingly early commitment for cells whose functional role is required during late and postnatal lung development. 
Gli1-cre ERT2 Labeled Myofibroblast Progenitors Progressively Commit to PDGFRa Expression
PDGFRa has been proposed as an early marker of smooth muscle and myofibroblast cell lineages [1, 2] . In PdgfA(2/2) lungs, parenchymal and scattered cells expressing PDGFA's sole receptor, PDGFRa were absent, but expression in PBSM and PVSM appeared normal [1] . Correspondingly, myofibroblast cell differentiation and alveolization in PdgfA(2/2) lungs were blocked. To ascertain the temporal relationship between Hh signaling as assessed by GFP pos status and PDGFRa expression, we examined the lungs of embryos and newborns from Gli1-cre
ERT2
;ROSA mTmG pregnant mice that received Tam on E10.5-E11.5. In E18.5, during the saccular stage of lung development, approximately 60% overlap was observed between GFP pos cells and those identified by immunostaining as PDGFRa pos ( Fig. 2A-2I ). In contrast, as the lungs developed to PN14 (alveolar stage) when extensive overlap between ACTA2 pos and GFP pos cells was clearly evident (Fig. 1 ) nearly all (97.2% 6 4.4%) GFP pos cells were also PDGFRa pos by immunostaining (Fig. 2J-2R ). The increase in GFP/PDGFRa double positive cells is unlikely caused by different proliferation rate of PDGFRa pos and PDGFRa neg cells, because it was reported that PDGFRa pos cells show decreased proliferation as compared to PDGFRa neg lung fibroblast [17] . Thus, there is progressive acquisition of PDGFRa expression by E10.5-E11.5 mesenchymal targets of Hh signaling as lung development proceeds. These data demonstrate that activation of Pdgfra expression occurs subsequent to commitment of the progenitor cells to ACTA2 pos lineage.
Hh Signaling Targets in Postnatal Lung
Hh signaling in the postnatal period of lung development has not been adequately studied. Therefore, we also examined the fate of cells receiving Hh signaling during the first week of life, a period during which alveolar formation is initiated. Newborn mice were treated with two doses of Tam on PN5 and PN6, and lungs were examined at two subsequent time points. Within a short window of only 5 days (PN11) subsequent to Tam administration, GFP pos cells appeared in four compartments including PBSM and PVSM layers (Fig. 3D-3I ). Rare but definitively GFP pos cells were also found in the mesothelium of PN11 lungs (Fig. 3A-3C ). The GFP pos cells in the PBSM and PVSM compartments were ACTA2 pos ( Fig. 3D-3I ). In addition, SCMFs were uniformly GFP pos indicating that they were recipients of Hh signaling in early postnatal lung development. The source of the Hh ligand at this time period 
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in lung development remains unexplored [18] . GFP pos SCMFs were also uniformly ACTA2 pos and PDGFRa pos (Fig. 3J-3O, 3R ). Importantly, as we found in Figure 3 , none of the GFP pos SCMFs labeled on PN5-PN6 was positive for oil red O staining (Fig. 3P-3R) .
Previous studies demonstrated that myofibroblasts are present specifically during alveolization and mostly disappear in normal adult lungs reflected as loss of ACTA2 pos expression [3] . This raised an interesting question regarding the fate of the GFP pos cells labeled during PN5-PN6 period; whether the GFP pos cells simply disappeared or survived but turned off Acta2 expression? We therefore determined the fate of the cells labeled on PN5-PN6 after a prolonged period extending to 3 months of age. Here, GFP pos cells or their progeny were found to survive within the PBSM (Fig. 4A-4C ) and the PVSM layers (Fig. 4D-4F ). There were also rare GFP pos cells in the mesothelial layer (Fig. 4G-4I) . Importantly, only a few GFP pos cells (less than 1% of total DAPI positive cells) were detected in the adult lung interstitium (Fig. 4J-4L ). Whether these surviving GFP pos cells are derived from a subpopulation of the IMF or other unidentified interstitial cells remains to be determined. Further characterization of the surviving GFP pos cells revealed they express a number of differentiated mesodermal markers including Desmin, NG2, and PDGFRb (Fig. 4M-4U) . These have been shown to be expressed in "pericyte-likecells" [19] . The GFP pos cells also express tropoelastin (data not shown). However, expression of S100A4 (also known as FSP1 [19] ) was not detected. Thus mesenchymal cells that are the target of Hh signaling on PN5-PN6 are found in multiple lung compartments with various differentiated mesenchymal phenotypes and survive to adulthood.
Transcriptomic Analysis of Myofibroblast Cell Differentiation
Based mostly on histologic criteria, embryonic lung development has been divided into somewhat distinct periods [20] . Transition from the pseudoglandular stage that ends the process of branching morphogenesis (E14.5) to the canalicular/ saccular stage (E18.5), which precedes alveolization (PN5-PN30) encompasses dramatic anatomical and cellular changes. Surprisingly, the molecular and genetic bases of this transition are poorly understood and represent a major challenge. In particular, multiple signaling pathways are thought to be involved in this transition [20] . The use of Gli1-cre ERT2 presented an opportunity to label and therefore isolate a highly specific pool of mesodermal progenitors and examine the dynamics of gene expression in such cells as they underwent pseudoglandular to saccular transition. Accordingly, Hhtargeted mesodermal progenitors were tagged in Gli1-cre ER-T2 ;ROSA mTmG lungs by two doses of Tam at E10.5-E11.5, and their GFP pos progeny were isolated from E14.5 and E18.5 lungs and purified by flow cytometry. The relative abundance of GFP pos cells between E14.5 and E18.5 lungs is around 0.45 (60.25, p 5 .02). Gene expression profiles of purified GFP pos cells were obtained on the Agilent gene array platform. The results were analyzed by comparative bioinformatics using the E14.5 versus E18.5 datasets. The microarray data were filtered for expression of various key functional categories of genes including levels of major signaling pathways. These analyses showed clear dynamic and profound changes (4,722 differentially expressed genes with >twofold change and FDR<0.05)
in genes belonging to all functional categories including transcription factors, signaling molecules, and extracellular matrix components (complete bioinformatic analysis of this study will be reported separately). In the signaling category, robust changes occurred in the WNT pathway whereby positive and negative regulators of the canonical WNT pathway were dynamically modulated (please see below and Table 1 ). Also, both transforming growth factor, beta (TGFb) and PDGFA/ PDGFRa pathways which are critical for myofibroblast differentiation increased significantly as cells transitioned from the pseudoglandular to the cannalicular/saccular phases of lung development. Thus, transition of Hh-targeted cells tagged in E10.5-E11.5 from the pseudoglandular to cannalicular/saccular phase of lung development, a period of major changes that has remained little understood is accompanied by robust modulation of many components of various signaling pathways, among which there are extensive functional interactions or crosstalk (Supporting Information Fig. SF1 ). We propose that it is the total sum of the interactions among these signaling engines that ultimately controls the profound anatomical, cellular, and molecular changes that occur during this critical period of embryonic lung development.
Ectopic Activation of Canonical WNT Signaling in Myofibroblast Progenitors by Apc Inactivation
A major finding of the transcriptomic analysis revealed alterations in a number of mediators of the WNT pathway with an overall decrease in canonical WNT activity as Hh-targeted mesodermal progenitors underwent transition from the pseudoglandular to the saccular phase of lung development (Table  1) . For example, the canonical WNT signaling target CCND1 was significantly reduced (8.7-fold decrease, p 5 1.04E-06). In contrast, inhibitors of the canonical WNT signaling were highly increased. These included WNT5a (increased 7.6-fold, p 5 2.77E-06), WIF (increased 23.8-fold, p 5 6.72E-05), DKK3 (increased 6.8-fold, p 5 1.03E-05), and TLE1 (increased 2.0-fold p 5 5.8E-04). These changes were validated by Realtime PCR (Supporting Information Table ST2 ). To determine the functional significance of decreased WNT signaling specifically in the Hh-targeted progenitors, we used Gli1-cre ERT2 and induced ectopic activation of WNT signaling by inactivating Apc, which encodes a component of the destructive complex for CTNNB1. Inactivation of Apc by Tam at E10.5 and E11.5 lead to increased canonical WNT activity represented by accumulation of CTNNB1 (Fig. 5) and increased LEF1 and AXIN2 expression (Supporting Information Fig. SF2 ). As a consequence, there was significant expansion of the mesodermal progenitor pools leading to formation of GFP pos focal masses, scattered within the lung parenchyma (Supporting Information  Fig. SF3 ). At E14.5, the expanded progenitor pools with accumulated CTNNB1 were PDGFRa neg and expressed no detectable ACTA2, indicating they remain as early progenitors of IMF (Fig. 5) . Proliferation of these cells is reduced as compared to the control lungs (Supporting Information Fig. SF2 ). Intriguingly, as the Gli1-cre
ERT2
;Apc flox/flox (Apc Gli1 ) lungs underwent further morphogenesis to E18.5, the expanded progenitor cells differentiated to a myofibroblast phenotype displaying robust expression of PDGFRa ACTA2, and fibronectin and eventually appearing as fibroblastic foci in the perinatal lungs (Fig. 5) . PRKAG2(protein kinase, AMP-activated, gamma 2 non-catalytic subunit) FGF signaling(12 genes) MAP2K6(mitgoen-activated protein kinase kinase6) FGF7(fibroblast growth factor 7) MAPK11(mitgoen-activated protein kinase 11) FGFR4(fibroblast growth factor receptor 4) PIK3R3(phosphoinositidde-3-kinase) PIK3R1(phosphoinositide-3-Kinase, regulatory subunit3(gamma) MAP3K5(mitogen-activated protein) FGFR3(fibroblast growth factor receptor 3) STAT3(signal transducer and activator of transcription 3) FGF18(fibroblast growth factor 18) PRKCA(protein kinase C, alpha) Creb5(cAMP responsive ellement binding protein 5)
Transcriptomic analyses of Gli1-cre
;ROSA mTmG labeled cells were conducted with Whole Mouse Genome Oligo Microarrays (Agilent) and IPA software. Differentially expressed genes (identified by IPA with greater than twofold changes and an FDR value less than 0.05) are listed. The left column shows genes of each signaling pathway that decrease from E14.5 to E18.5. The right column shows genes of each signaling pathway that increase from E14.5 to E18.5. Abbreviations: EGF, epidermal growth factor; FGF, fibroblast growth factor; IGF, insulin-like growth factor; PDGF, platelet-derived growth factor; TGF, transforming growth factor; Wnt, wingless-type MMTV integration site family; Shh, Sonic Hedgehog.
DISCUSSION
Cross-communication between the epithelium and its mesenchymal counterpart, a requirement in development of the lung and differentiation of its highly specialized cell types is predicated on key signaling pathways including fibroblast growth factor 10 (FGF10), bone morphogenetic protein 4 (BMP4), TGFb, Wnt, and Hh. Shh is produced by the lung epithelium early in its morphogenesis and imparts specific 
IMFs become ACTA2
pos only in late embryonic or postnatal lung development and get lost in adult lungs. Owing to lack of specific markers, little is known regarding the lineage of IMFs. This study demonstrates that Gli1-cre ERT2 represents a useful in vivo genetic tool to label, trace, and target IMF. Even though some PBSM and PVSM cells are also labeled by Gli1-cre
ERT2
, these cells are easily distinguishable in the embryonic stage from IMF progenitors based on their anatomic location and gene expression (i.e., ACTA2). Accordingly, we used Gli1-cre ERT2 mice to first identify and then lineage trace Hh signaling targets during embryonic and postnatal lung development. Identification of Hh targets was based on GFP expression resulting from activation of Gli1 in Gli1-cre ERT2 ;ROSA mTmG lungs by two doses of Tam, 24 hours apart. This was done either during early embryonic development at E10.5-E11.5 or during postnatal lung development on PN5-PN6. Given the approximate 30 hour duration of Tam activity, we used the observations on E12.5 as baseline.
The majority of cells labeled by Gli1-cre ERT2 in E10.5-E11.5 embryonic lungs were localized to the subepithelial mesoderm (Fig. 1) . Shh is expressed by the pseudoglandular distal epithelium and acts on the adjacent subepithelial mesenchyme [21] . Consistent with the known range of Hh signaling, this implies that only the mesenchyme immediately proximal to the branching epithelium receives signaling. However, we also found GFP pos cells distantly localized in the submesothelium and also within the mesothelium (Fig.  1) . Hh ligands are secreted proteins whose spatial range of activity can be expanded by moieties such as cholesterol on its carboxyl terminus. Hh signaling is also dependent on proteoglycans and heparan sulfate synthesis by the target cells (on the range of hedgehog signaling). We cannot rule out the possibility of cell migration as the basis for the distantly localized GFP pos cells. Because SCMFs appear specifically at the alveolar stage, it is obvious that E10.5-E11.5, Gli1-cre 
/ACTA2
pos cells localized to the PBSM or PVSM of E12.5 lungs remains questionable. ACTA2
pos cells are found around the bifurcation of mainstem bronchi as early as E11.5 [22] . Therefore, we cannot rule out the likely possibility that Gli1-cre ERT2 targets a select group of differentiated PBSM cells, which remain Hhresponsive. Progenitors of PBSM are proposed to be derived at least partly from FGF10 pos cells in the submesothelial mesoderm [4] . These cells are thought to migrate along the branching airways in a distal to proximal direction and undergo differentiation to become ACTA2 pos in response to SHH [23] . The origin of PVSM of the intralobular blood vessels remains to be determined. Wnt2
pos cardiopulmonary mesoderm progenitors tagged at E8.5 have been shown to give rise to pulmonary PVSM, PBSM as well as cardiomyocytes [24] . In contrast to the progressive (or sequential) pattern of PBSM differentiation, SCMF progenitors differentiate to ACTA2 pos cells in a synchronous manner (Fig. 1) . These progenitor cells, which are first identified as interstitially scattered Gli1 pos with no detectable expression of ACTA2 display PDGFRa in midcanalicular development [2] , but subsequently become ACTA2 pos in near unison in the postnatal lung (Figs. (1 and 2) ). In sum, the evidence strongly supports a model that cells labeled by Gli1-cre ERT2 in E10.5-E11.5 represent progenitors of IMFs, which subsequently undergo differentiation to SCMFs during alveolization. This conclusion is further supported by the transcriptomic analysis (please see below).
The finding that Hh signaling as early as E10.5 establishes the commitment of SCMFs, a key and the least understood cell type in the lung is an important advancement that will undoubtedly facilitate the study of alveolar formation. . During myofibroblast differentiation, Wnt signaling controls the size of the progenitor pool. During saccular stage of lung development, PDGFA signaling is thought to be required for migration and distribution of myofibroblast progenitors to the lung interstitium to facilitate secondary crest formation, a key step in alveogenesis. Differentiated myofibroblasts localize to the tip of secondary crests and areas of the primary septa and express ACTA2 and PDGFRa. Abbreviations: PDGFA, plateletderived growth factor-A; Shh, Sonic Hedgehog; Wnt, winglesstype MMTV integration site family. Alveogenesis is the last phase of lung development during which functional units of gas exchange are generated. In humans, alveogenesis commences in utero, but the process continues postnatally. In mice, the postnatal period spanning PN5-PN30 marks the process of alveolar formation. During alveogenesis, secondary septa subdivide the saccular space, thereby significantly expanding the gas exchange area. Septation requires elastic fibers deposited in the extracellular matrix by SCMFs whose identity and characteristics had hitherto remained poorly defined [20] . Topographically, SCMFs are localized to the alveolar septa. A major obstacle in characterization of SCMFs has been lack of technical ability to isolate them for detailed analysis. Lineage tracing of GFP pos cells tagged on E10.5-E11.5, a period of at least 7-10 days prior to the onset of alveogenesis clearly shows that this population harbors the progenitors of SCMFs (Fig. 1) . Indeed we also found that SCMFs continue to receive Hh signaling during alveogenesis (Fig. 3 ). This result is consistent with the observation using Gli1 nlacZ model by Liu et al. [18] . The source of Hh ligand in the postnatal lung remains unexplored.
Based on collective and currently available data, we propose a model (Fig. 6 ) in which Hh signaling is the key determinant of the multipotential mesenchymal cell commitment to the ACTA2 pos lineage, as there is a purported lack of ACTA2 pos cell types in Shh(2/2) lungs [5] . This decision point, regulated by Shh, is marked by activation of Gli1 and using this information, we have now labeled and traced the progenitors and descendants of this lineage using the Gli1-cre ERT2 mice [13] . Subsequent to Shh, PDGFA is key in regulating the decision that separates the fate of smooth muscle cells (PBSM and PVSM) from that of SCMFs. In PdgfA(2/2) lungs, SCMFs are absent and alveogenesis is blocked, while the PBSM and PVSM appear intact [1] . In these lungs, elastin is significantly diminished and expression of PDGFAs' sole receptor Pdgfra on scattered IMFs, normally observed in wild type embryonic lungs is missing. Interestingly, PDGFRa pos cells and elastin fibers within the PBSM and PVSM are intact. This suggests that Pdgfra activation occurs subsequent to Shh and Gli1 and in the smooth muscle lineage is independent of PDGFA. In contrast, Pdgfra expression in progenitors of SCMF is dependent on PDGFA signaling. Thus, PDGFA is required for establishment of SCMF, but not PBSM or PVSM from a common Gli1 pos progenitor cell population. Consistent with this model, reduction of PDGFRa does not significantly disrupt PBSM cells in E14.5 Gli1-cre
ERT2
;Apc flox/flox lungs (Fig. 5 ). PDGFRa has been hitherto recognized as the earliest marker of SCMF progenitors [2] . Our findings demonstrate that Hh signaling precedes PDGFRa expression. In E18.5 lungs, we found only partial overlap between GFP pos and PDGFRa pos cells (Fig. 2) . However, by P14, nearly all GFP pos cells had become both PDGFRa pos and ACTA2 pos (Figs. (1 and 2) ). This observation was validated by the microarray analysis, which showed that Pdgfra transcripts significantly increased (5.67-fold, p < .005) in the Gli1-cre
-labeled cells transitioning from E14.5 to E18.5 phases of lung development.
Of note, in E18.5 Gli1-cre
; ROSA mTmG lungs, a large portion (60.2% 6 9.8%) of PDGFRa pos cells are GFP neg . The origin and lineage of these cells remain unknown. One possibility is that not all SCMF progenitors are exposed to Shh signaling around E10.5 and E11.5. Another possibility is that not all PDGFRa pos cells serve as SCMF progenitors, even though PDGF-A signaling is required for SCMF differentiation. In agreement with this possibility, Chen et al. [25] reported that during compensatory lung growth, only a subset of PDGFRa pos cells (the dim PDGFRa expressing cells) serve as myogenic precursors.
Smooth muscle differentiation is also dependent on canonical WNT (WNT/CTNNB1) signaling [26] [27] [28] . Wnt7b broadly regulates the development of smooth muscle [28] . In Wnt7b (2/2) mice, PVSM development is disrupted causing perinatal pulmonary hemorrhage [29] . Wnt2 acts upstream of Fgf10 and the critical transcription factors myocardin and Mrtf-B to regulate early smooth muscle cell differentiation [30] . The role of Wnt2 or Wnt7b in SCMF has not been investigated. In this study, we found the role of canonical WNT signaling during IMF differentiation to be more complex. In early stages (i.e., E14.5), WNT appears to be critical for regulating the pool of IMF. Ectopic activation of WNT signaling lead to expansion of this progenitor pool, which resulted in perinatal appearance of mesodermal cellular masses. Therefore, reduced WNT signaling observed in the transcriptomic analysis (Table 1) is likely related to controlling the size of the IMF progenitor pool.
Disruption of a number of signaling pathways causes abnormal alveolar development. For example, insulin-like growth factor 1 (IGF1) deficiency in mice disrupts alveologenesis and leads to neonatal death [31] . Transcriptomic analysis in Igf1(2/2) lungs revealed reduced expression of two major genes; Klf2 and Egr1 suggesting their potential involvement [31] . Our microarray analysis showed increased transcripts for multiple mediators of IGF pathway during the transition of Hh-targeted wild type mesodermal cells from E14.5 to E18.5 (Table 1) . Klf2 increased by 17.29-fold (p < .005) and Egr1 by 18.91-fold (p < .005) prior to the onset of alveogenesis. Of interest, treatment of Igf1(2/2) lungs with IGF1 increased distal lung maturation and expression of Klf2 and Cyr61. Our array analysis also showed an 11.4-fold increase in Cyr61 (p < .005). Collectively, these findings support the assertion that the GFP pos cells tagged on E10.5-E11.5 represent a cell population with properties consistent with those of SCMFs and their role in alveologenesis.
The mechanisms that regulate late-stage myofibroblast differentiation may involve interactions of multiple pathways. For example, transcripts for several mediators of TGFb, IGF, and PDGF signaling are increased during the E14.5 ! E18.5 transition ( Table 1 ). The precise "signaling stoicheometery" between Wnt and TGFb, IGF and PDGF may be critical in achieving normal SCMF differentiation, which in turn is essential for alveogenesis. But ultimately the dynamics, and precisely "regulated" interactions among multiple signaling pathways appears necessary for proper differentiation of myofibroblast progenitors. In this study, alterations in a single signaling pathway, that of WNT alone in Gli1-cre
;Apc flox/flox lungs caused a phenotype similar but not identical to the fibroblastic masses found in interstitial pulmonary fibrosis (IPF). Not identical, as the clinical IPF is a highly complex pathology that includes not only fibroblastic masses (as in Gli1-cre
;Apc flox/flox lungs) but also epithelial malfunction [32, 33] . Increased canonical WNT signaling has been observed in human and experimental IPF, but it is usually combined with alterations in multiple other signaling pathways, such as TGFb, PDGF, and IGF [34, 35] . As the change 
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in WNT signaling via inactivation of Apc by Gli1-cre ERT2 was induced at a specific time and only in a specific subpopulation of mesodermal cells, these findings raise the intriguing possibility that this population may be particularly sensitive to alterations in Wnt signaling and prone to contributing to mesenchymal masses like those found in IPF. Whether as such this cell population may contribute to and thus represent a new and potential therapeutic target in IPF remains a future challenge.
CONCLUSIONS
Our studies demonstrate that progenitors of alveolar or secondary crest myofibroblasts are committed during early lung development. Differentiation of alveolar myofibroblast is regulated by interactions amongst multiple signaling pathways including PDGFA, TGFb and WNT. The Gli1-creERT2 mouse line represents a novel tool in studying the mechanism of myofibroblast cell differentiation and alveolar formation during lung development.
